Walleye Capital
THRD

Walleye Capital’s Third Harmonic Bio THRD Stock Holding History

Walleye Capital’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,275
Closed -$132K – 5123
2025
Q2 		$132K Sell
24,275
-77,982
-76% -$389K ﹤0.01% 3633
2025
Q1 		$355K Buy
102,257
+53,872
+111% +$261K ﹤0.01% 2828
2024
Q4 		$498K Sell
48,385
-34,051
-41% -$424K ﹤0.01% 2987
2024
Q3 		$1.12M Buy
82,436
+41,745
+103% +$517K ﹤0.01% 2551
2024
Q2 		$529K Buy
40,691
+19,365
+91% +$240K ﹤0.01% 3463
2024
Q1 		$201K Buy
+21,326
New +$207K ﹤0.01% 3971
2023
Q2 		– Sell
-50,000
Closed -$206K – 4878
2023
Q1 		$206K Sell
50,000
-6,900
-12% -$29.3K ﹤0.01% 2449
2022
Q4 		$245K Buy
+56,900
New +$952K ﹤0.01% 1917

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Walleye Capital's THRD Position: Q3 2025 in Review

Walleye Capital sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 24,275 shares — an estimated $132K sold.

Walleye Capital first reported a position in THRD in Q4 2022 and held it in 8 quarters. The position peaked at $1.12M in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Walleye Capital reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Walleye Capital sold 24,275 Third Harmonic Bio shares in Q3 2025, an estimated $132K.
  • Walleye Capital first reported a position in Third Harmonic Bio in Q4 2022 and held it in 8 quarters.
  • Walleye Capital's Third Harmonic Bio position peaked at $1.12M in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.